Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
KL1333
Tag: KL1333
Abliva’s mission to become mitochondrial medicine powerhouse
8 April, 2024
Abliva reaches enrollment goal
21 December, 2023
Abliva’s CEO: ”Orphan drug designation is great validation”
15 December, 2023
Abliva signs global license deal for NeuroSTAT
16 November, 2023
Abliva’s VP of Clinical Operations on the screening achievement
18 October, 2023
Abliva increases awareness of mitochondrial diseases
19 September, 2023
Abliva receives FDA Fast Track designation
8 September, 2023
First patient dosed in Abliva’s Falcon study
30 June, 2023
Abliva’s presence is felt at Euromit
14 June, 2023
FDA grants Abliva’s NV354 Orphan Drug Designation
19 April, 2023
1
2
Page 1 of 2